Residues of hazardous waste pharmaceuticals in empty containers

1. Stock, dispensing, and unit-dose containers. A stock bottle, dispensing bottle, vial, or ampule, not to exceed one liter or ten thousand pills; or a unit-dose container, e.g., a unit-dose packet, cup, wrapper, blister pack, or delivery device, is considered empty and the residues are not regulated as hazardous waste provided the pharmaceuticals have been removed from the stock bottle, dispensing bottle, vial, ampule, or the unit-dose container using the practices commonly employed to remove materials from that type of container. 2. Syringes. A syringe is considered empty and the residues are not regulated as hazardous waste under sections 33.1-24-05-310 through 33.1-24-05-320 provided the contents have been removed by fully depressing the plunger of the syringe. If a syringe is not empty, the syringe must be placed with its remaining hazardous waste pharmaceuticals into a container that is managed and disposed of as a noncreditable hazardous waste pharmaceutical under these requirements and any applicable federal, state, and local requirements for sharps containers and medical waste. 3. Intravenous (IV) bags. An IV bag is considered empty and the residues are not regulated as hazardous waste provided the pharmaceuticals in the IV bag have been fully administered to a patient. If an IV bag is not empty, the IV bag must be placed with its remaining hazardous waste pharmaceuticals into a container that is managed and disposed of as a noncreditable hazardous waste pharmaceutical under sections 33.1-24-05-310 through 33.1-24-05-320, unless the IV bag held nonacute hazardous waste pharmaceuticals and is empty as defined in subsection 3 of section 33.1-24-02-07. 4. Other containers, including delivery devices. Hazardous waste pharmaceuticals remaining in all other types of unused, partially administered, or fully administered containers must be managed as noncreditable hazardous waste pharmaceuticals under sections 33.1-24-05-310 through 33.1-24-05-320, unless the container held nonacute hazardous waste pharmaceuticals and is empty as defined in subsection 3 or 4 of section 33.1-24-02-07. This includes residues in inhalers, aerosol cans, nebulizers, tubes of ointments, gels, or creams.